Epinephrine
Who holds supplier records for Epinephrine? 13 organisations hold a current record for Epinephrine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (3), Italy (2), Germany (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Epinephrine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/epinephrine
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Epinephrine expires 17 Jan 2045. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Epinephrine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 38733, 35384 · latest filing Sept 2023
- CAMBREX PROFARMACO MILANO SRLItalyCEP Company GMP cert on recordActive DMF 25989 · latest filing Apr 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 28749 · latest filing Dec 2014
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 40796 · latest filing Dec 2024
- TRANSO PHARM HANDELS GMBHGermanyCEP Company GMP cert on recordActive DMF 30996 · latest filing Sept 2016
- Amphastar Nanjing PharmaceuticalsChinaActive DMF 33036 · latest filing Aug 2018
- CURIA NEW YORK INCActive DMF 29210 · latest filing Jul 2015
- MALLADI DRUGS AND PHARMACEUTICALS LTDIndiaActive DMF 44608 · latest filing Sept 2026
- PHLOW CORPUnited StatesActive DMF 37581 · latest filing Dec 2024
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28617 · latest filing Sept 2014
- Wockhardt LimitedIndia Company GMP cert on recordActive DMF 21213 · latest filing Dec 2007
- Zhejiang Boxiao Biopharmaceutical Co., Ltd.ChinaActive DMF 43156 · latest filing Nov 2025
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Epinephrine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| OLON S.P.A. Rodano | IT | CEP 2024-560 - Rev 00 Adrenaline | Sept 2026 | Inspected Mar 2025 Italy |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2015-006 - Rev 03 Adrenaline | Jul 2026 | — |
| TRANSO PHARM HANDELS GMBH Siek | DE | CEP 2016-232 - Rev 01 Adrenaline | Jul 2026 | Inspected Dec 2025 Germany |
| WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi | CN | CEP 2020-192 - Rev 03 Adrenaline | Jun 2026 | — |
| CAMBREX PROFARMACO MILANO S.R.L. Paullo | IT | R1-CEP 2013-266 - Rev 01 Adrenaline | Jan 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Epinephrine are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Germany · Inactive DMF 5822 · filed May 1985
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (44 listed products contain Epinephrine). The latest listed patent expires 17 Jan 2045. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Epinephrine is a hormone and a neurotransmitter that plays an important role in the body's acute stress response and acts on both alpha and beta-adrenergic receptors. It is commonly used in emergencies to treat cardiac arrest, anaphylaxis, and other conditions requiring immediate action.
Chemical identity
- IUPAC name
- 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
- Canonical SMILES
- CNC[C@@H](C1=CC(=C(C=C1)O)O)O
- InChIKey
- UCTWMZQNUQWSLP-VIFPVBQESA-N
- Synonyms
- Adrenaline, (-)-(r)-epinephrine, (-)-epinephrine, adrenalinum, anapen, bronkaid mist, epinephrinum, epipen, glauposine, iontocaine component epinephrine, neffy, nephridine
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- alpha-Adrenergic Agonist; beta-Adrenergic Agonist; Catecholamine
- Mechanism of action
- Adrenergic alpha-Agonists; Adrenergic beta-Agonists
- Chemical structure
- Catecholamines
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Epinephrine?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Epinephrine: GLAND PHARMA LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy), MATRIX PHARMACORP PRIVATE LTD (India), OLON SPA (Italy), TRANSO PHARM HANDELS GMBH (Germany), Amphastar Nanjing Pharmaceuticals (China), CURIA NEW YORK INC and MALLADI DRUGS AND PHARMACEUTICALS LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Epinephrine Drug Master Files are active?
GLAND PHARMA LTD (DMF 38733, 35384), CAMBREX PROFARMACO MILANO SRL (DMF 25989), MATRIX PHARMACORP PRIVATE LTD (DMF 28749), OLON SPA (DMF 40796), TRANSO PHARM HANDELS GMBH (DMF 30996), Amphastar Nanjing Pharmaceuticals (DMF 33036), CURIA NEW YORK INC (DMF 29210) and MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 44608) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Epinephrine records mean?
1 organisation has only inactive Type II DMFs for Epinephrine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Epinephrine have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Epinephrine on the EDQM register, including OLON S.P.A. Rodano (IT), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), TRANSO PHARM HANDELS GMBH Siek (DE), WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi (CN) and CAMBREX PROFARMACO MILANO S.R.L. Paullo (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Epinephrine?
Yes. The latest patent listed for an approved US product containing Epinephrine expires 17 Jan 2045, across 44 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Epinephrine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Epinephrine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.